ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 107658 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 107658; 2) Community: the network communities that were significantly associated with the response to NSC 107658; 3) Molecule: the relationships between components within communities and NSC 107658; 4) MDR: the compounds that were significantly associated with the NSC 107658.

NSC Compound Enrichment Correlation
NSC 609699 Topotecan hydrochloride 0.0312262198176281 0.18283219
NSC 611377 Null 0.0312262198176281 0.16045113
NSC 619859 1H-3-Benzazepin-2-one, 2,3,4,5-tetrahydro-7,8-dimethoxy- 3-[(2,3-dimethoxyphenyl)methyl]-1-methylthio- 0.0312262198176281 -0.1162963
NSC 639734 Null 0.0312262198176281 0.18727727
NSC 644621 Null 0.0312262198176281 -0.20270858
NSC 658247 Pyridine-3,5-dicarboxylic acid, 1,4-dihydro-2,6-dimethyl-, bis[2-(2-hydroxybenzoyl)hydrazide] 0.0312262198176281 0.15232402
NSC 659948 7-O-(2,3,6-Trideoxy-2-fluoro-.alpha.-L-talo-hexopyranosyl)-4-demethoxydaunomycinone 0.0312262198176281 0.3630196
NSC 659950 7-O-(3,4-Di-O-acetyl-2,3,6-trideoxy-2-fluoro-.alpha.-L-talo-hexopyranosyl)-4-demethoxydaunomycinone 0.0312262198176281 0.24290923
NSC 676775 Olean-12-en-28-oic acid, 3-.beta.-[2-O-(.beta.-D-glucopyranosyl)- .beta.-D-glucopyranosyloxy]-, [2-O-[[4-O-[3-O-(.beta.-L-arabinopyranosyl)- .beta.-D-xylopyranosyl]-3-O-.beta.-D-xylopyranosyl]- 6-deo 0.0312262198176281 -0.2686345
NSC 678403 Null 0.0312262198176281 -0.14380958
Total:47  Current:28    [First] [Prev] [Next] [Last]